Bainan Biotech (private company)

Bainan Biotech is a spinout company is founded based on research exploring the connection between gut hormones and bone turnover, carried out at the University of Copenhagen.

Bainan aims to utilise the natural responses to eating in order to promote the formation of stronger and healthier bone tissue and develop effective treatments for osteoporosis. Specifically, the products are adapted to be effective in premenopausal women, a patient group which currently is vastly under-served in this area.